Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hutchmed (HCM) Share Price

Price 260.00p on 12-09-2025 at 18:30:06
Change 21.00p 8.79%
Buy 263.00p
Sell 258.00p
Last Trade: Buy 946.00 at 260.00p
Day's Volume: 133,927
Last Close: 260.00p
Open: 243.00p
ISIN: KYG4672N1198
Day's Range 243.00p - 266.00p
52wk Range: 187.50p - 336.00p
Market Capitalisation: £2.23b
VWAP: 259.7111p
Shares in Issue: 859.30m

Hutchmed (HCM) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 946 260.00p Suspected BUY Trade
16:35:15 - 12-Sep-25
Buy* 1,900 263.0862p Ordinary
16:28:58 - 12-Sep-25
Sell* 16 262.00p Automatic Execution
16:03:16 - 12-Sep-25
Sell* 2,068 262.00p Automatic Execution
16:03:16 - 12-Sep-25
Buy* 2,573 266.00p Automatic Execution
16:03:16 - 12-Sep-25
Buy* 83 259.00p Automatic Execution
16:03:16 - 12-Sep-25
Buy* 2,305 259.00p Automatic Execution
16:03:16 - 12-Sep-25
Buy* 83 259.00p Automatic Execution
16:03:16 - 12-Sep-25
Buy* 83 259.00p Automatic Execution
16:03:16 - 12-Sep-25
Sell* 158 260.00p Automatic Execution
16:03:16 - 12-Sep-25
See more Hutchmed trades

Hutchmed (HCM) Share Price History

Time period:
to
Date Open High Low Close Volume
12th Sep 2025 (Fri) 243.00 266.00 243.00 260.00 133,927
11th Sep 2025 (Thu) 238.00 239.00 233.00 239.00 6,252
10th Sep 2025 (Wed) 232.00 233.00 232.00 233.00 3,416
9th Sep 2025 (Tue) 234.00 235.00 234.00 235.00 10,517
8th Sep 2025 (Mon) 239.00 239.00 231.00 231.00 61,682
5th Sep 2025 (Fri) 228.00 237.00 228.00 233.50 149,950
4th Sep 2025 (Thu) 222.00 222.00 215.00 215.00 30,412
3rd Sep 2025 (Wed) 221.00 223.00 219.00 227.50 18,358
2nd Sep 2025 (Tue) 228.00 230.00 227.00 227.00 22,827
1st Sep 2025 (Mon) 231.00 231.00 218.00 218.00 15,077
29th Aug 2025 (Fri) 225.00 225.00 218.00 222.00 11,701
28th Aug 2025 (Thu) 217.00 222.00 216.00 218.50 5,945
27th Aug 2025 (Wed) 226.00 228.00 215.00 226.00 58,851
26th Aug 2025 (Tue) 234.00 235.00 224.00 227.50 72,694
25th Aug 2025 (Mon) 236.00 236.00 236.00 236.00 0
22nd Aug 2025 (Fri) 239.00 239.00 239.00 236.00 10,131
21st Aug 2025 (Thu) 240.00 240.00 237.00 237.00 3,450
20th Aug 2025 (Wed) 237.00 237.00 231.00 236.50 5,349
19th Aug 2025 (Tue) 238.00 241.00 236.00 241.00 58,193
18th Aug 2025 (Mon) 244.00 247.00 235.00 235.00 32,223
15th Aug 2025 (Fri) 240.00 243.00 235.00 243.00 20,953
14th Aug 2025 (Thu) 234.50 234.50 234.00 234.00 6,830
13th Aug 2025 (Wed) 234.00 238.00 228.00 234.50 43,708
See more Hutchmed price history

Hutchmed (HCM) Regulatory News

Date Source Headline
12th Sep 2025 7:00 am RNS-R HUTCHMED to Present R&D Updates on October 31 2025
5th Sep 2025 7:00 am RNS-R HUTCHMED Highlights Data to be Presented at CSCO
26th Aug 2025 7:00 am RNS Directorate Change
20th Aug 2025 7:00 am RNS-R HUTCHMED Completes Enrollment of Phase III Trial
7th Aug 2025 12:00 pm RNS 2025 Interim Results
3rd Jul 2025 9:30 am RNS HUTCHMED to Announce 2025 Half-Year Results
2nd Jul 2025 10:00 am RNS Update on Joint Corporate Brokers in London
30th Jun 2025 9:30 am RNS China Approval based on Phase III SACHI Trial
30th Jun 2025 9:30 am RNS Total Voting Rights
30th Jun 2025 9:30 am RNS Blocklisting Six Monthly Return
See more Hutchmed regulatory news

Hutchmed (HCM) Share News

Hutchmed China CFO Cheng is interim CEO as CEO Su takes health leave

26th Aug 2025 09:14

(Alliance News) - Hutchmed China Ltd on Tuesday said Chief Executive Officer Weiguo Su will take a leave of absence for health reasons. Read More

Hutchmed China completes enrollment for phase three lung cancer trial

20th Aug 2025 10:55

(Alliance News) - Hutchmed China Ltd on Wednesday said it has completed patient enrollment of Sanovo, a phase three trial of Orpathys and Tagrisso. Read More

Hutchmed China interim profit jumps on joint venture stake disposal

7th Aug 2025 14:33

(Alliance News) - Hutchmed China Ltd on Thursday reported a jump in profit during the first half of its current financial year, and forecasts a full-year decline in its key Oncology/Immunology segment. Read More

UK earnings, trading statements calendar - next 7 days

31st Jul 2025 14:25

Read More

Hutchmed reports progress in late-stage lung cancer trial

2nd Jun 2025 11:19

(Alliance News) - Hutchmed China Ltd on Monday said its combination therapy for a specific form of advanced lung cancer significantly delayed disease progression compared to chemotherapy, based on phase III trial data presented at a major oncology conference. Read More

See more Hutchmed news
FTSE 100 Latest
Value9,283.29
Change-14.29

Login to your account

Forgot Password?

Not Registered